Sodium chloride IV solution
Product-specific saline information; concentrations and routes are not interchangeable.
FDA-approved product context
Product-specific saline information; concentrations and routes are not interchangeable.
Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.
Evidence and source limits
The retrieved sodium chloride injection label concerns a 0.45% intravenous product for parenteral fluid and sodium-chloride replenishment as required by the clinical condition. Its marketing table identifies an ANDA. This entry does not substitute it for other saline concentrations.
Fluid or solute overload, pulmonary edema and sodium retention are among the labeled concerns, especially with kidney or heart disease. No infusion recipe is supplied.
Approval applies to the specific labeled product, route and indication, not every preparation of this ingredient or a wellness mixture. Read the original full label and discuss individual circumstances with a medical professional. No dosing or preparation instructions are included.
Original source: Sodium chloride IV solution ↗
Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.